|
|
User Functions
|
|
|
Don't have an account yet? Sign up as a New User
|
|
|
|
Events Block
|
|
|
There are no upcoming events |
|
|
|
 |
|
Experts advise WHO on pandemic vaccine policies and strategies
|
|
 |
Sunday, November 01 2009 @ 03:16 PM CST Contributed by: Admin
Views: 108
|
GENEVA -- The Strategic Advisory Group of Experts (SAGE) on Immunization, which advises WHO on policies and strategies for vaccines and immunization, devoted a session of its 27–29 October meeting to pandemic influenza vaccines. The experts reviewed the current epidemiological situation of the pandemic worldwide and considered issues and options from a public health perspective.
Items on the agenda included the status of vaccine availability, results from clinical trials on vaccine immunogenicity, and early results from safety monitoring in countries where administration of the H1N1 pandemic vaccine is currently under way.
The experts also advised WHO on the number of doses of vaccine needed to confer protection, also in different age groups, the co-administration of seasonal and pandemic vaccines, and vaccines for use in pregnant women. Recommendations on the formulation of seasonal influenza vaccines for the southern hemisphere in 2010 were also provided.
Current situation
Globally, teenagers and young adults continue to account for the majority of cases, with rates of hospitalization highest in very young children. Between 1% to 10% of patients with clinical illness require hospitalization. Of hospitalized patients, from 10% to 25% require admission to an intensive care unit, and from 2% to 9% have a fatal outcome.
Overall, from 7% to 10% of all hospitalized patients are pregnant women in their second or third trimester of pregnancy. Pregnant women are ten times more likely to need care in an intensive care unit when compared with the general population.
Based on these and other current findings, the experts made a number of recommendations.
Single dose recommended
The experts noted that a variety of pandemic vaccines, including live attenuated and both adjuvanted and non-adjuvanted inactivated vaccines, have now been licensed for use by regulatory authorities. SAGE recommended the use of a single dose of vaccine in adults and adolescents, beginning at the age of 10 years, provided such use is consistent with indications from regulatory authorities.
Data on immunogenicity in children older than 6 months and younger than 10 years are limited and more studies are needed. Where national authorities have made children a priority for early vaccination, SAGE recommended that priority be given to the administration of one dose of vaccine to as many children as possible. SAGE further stressed the need for studies to determine dosage regimens effective in immunocompromised persons.
Co-administration of vaccines
Clinical trials investigating the co-administration of seasonal and pandemic vaccines are ongoing, but SAGE acknowledged the recommendation, from the US Centers for Disease Control and Prevention, that live attenuated seasonal and live attenuated pandemic vaccines should not be co-administered.
The experts recommended that seasonal and pandemic vaccines can be administered simultaneously, provided both vaccines are inactivated, or one is inactivated and the other is live attenuated. The experts found no evidence that co-administration of vaccines, as recommended, would increase the risk of adverse events.
Vaccine safety
The experts reviewed early results from the monitoring of people who have received pandemic vaccines and found no indication of unusual adverse reactions. Some adverse events following vaccination have been notified, but these are well within the range of those seen with seasonal vaccines, which have an excellent safety profile. Although early results are reassuring, monitoring for adverse events should continue.
Vaccines for pregnant women
Concerning vaccines for pregnant women, SAGE noted that studies in experimental animals using live attenuated vaccines and non-adjuvanted or adjuvanted inactivated vaccines found no evidence of direct or indirect harmful effects on fertility, pregnancy, development of the embryo or fetus, birthing, or post-natal development.
Based on these data and the substantially elevated risk for a severe outcome in pregnant women infected with the pandemic virus, SAGE recommended that any licensed vaccine can be used in pregnant women, provided no specific contraindication has been identified by the regulatory authority.
Vaccines for the southern hemisphere in 2010
SAGE also considered vaccines for use in the southern hemisphere during the 2010 winter season. Two options were assessed: a
|
|
| |
 |
read more (62 words)
|
|
|
Heart Disease No. 1 Killer of Women
|
|
 |
Thursday, February 26 2009 @ 09:16 PM CST Contributed by: Admin
Views: 108
|
(inan.info)-voanews-By Faiza Elmasry
Washington, D.C.
Heart disease is the No. 1 killer of women in the United States, but many women are not aware of that. Health experts say informing women about the risk of developing the disease is the first step in preventing it.
Women today are more likely than ever to suffer from heart disease, says cardiologist Matthew Budoff.
Women are more likely to develop heart problems as they age
"They are actually at increased risk of heart disease, partly because they live longer," he says. "And so, as they get older, they are more likely to develop high blood pressure, diabetes, and their cholesterol goes up. A lot of these issues are not discussed with their primary care physicians as diligently as men."
The first step toward fighting the disease among
|
|
| |
 |
read more (641 words)
|
|
|
Avian Influenza and the Threat of a Pandemic Are Serious Risks to World Health
|
|
 |
Thursday, October 23 2008 @ 08:36 PM CDT Contributed by: Admin
Views: 158
|
-By Libby Massey
Ambassador John E. Lange leads the U.S. Government’s engagement with international organizations to help respond to outbreaks of avian influenza
Ambassador John E. Lange, former U.S. Ambassador to Botswana, currently Special Representative on Avian and Pandemic Influenza at the U.S. Department of State, says avian influenza and the threat of a pandemic are serious risks to world health. He cautioned that if the avian virus (also known as H5N1) mutates and forms a pandemic like the one in 1918, it could kill tens of millions of people throughout the world.
Ambassador Lange spoke with host Carol Castiel, VOA Science and Medicine Correspondent Jessica Berman, and VOA Producer Libby Massey on Press Conference, USA in Washington in advance of the 6th International Ministerial Conference on Avian and Pandemic Influenza in Sharm el Sheikh, Egypt on October 24-26, 2008.
Ambassador Lange explained that avian influenza is most prevalent in Egypt, Bangladesh, Nigeria, Indonesia, and other countries in
|
|
| |
 |
read more (222 words)
|
|
First | Previous | 1 2 3 4 5 6 7 8 9 10 | Next | Last |
 |
|
UnitedStates-America.net
|
|
|
Welcome to our site. We welcome your information, ideas and thoughts. Please feel free to "get published", add your press releases for others to view, write your own articles, put in your own dates and events and participate with UnitedStates-America.net.
|
|
|
|
Add Your Press Release
|
|
|
Now You Can Add Your Own Press Release for FREE! Just click on "Get Published" and add your important information. UnitedStates-America.net is inviting all who want newsmedias all over the world to read their news releases to enter it HERE for FREE. This is a MUST opportunity for all those wanting to get their business information into the main-stream media. Now for a limited time, YOU can have your press release covered right here and available for news outlets all over the world.
|
|
|
|
Whats New
|
|
STORIES No new stories
COMMENTS last 48 hrs No new comments
LINKS last 2 wks No recent new links
|
|
|
|